These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL; Watson KD; Silman AJ; Symmons DP; Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [TBL] [Abstract][Full Text] [Related]
7. The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden. Kristensen LE; Saxne T; Geborek P Arthritis Rheum; 2006 Feb; 54(2):600-6. PubMed ID: 16447237 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of rheumatoid arthritis. Rindfleisch JA; Muller D Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501 [TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007? Yazici Y; Abramson SB Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549 [TBL] [Abstract][Full Text] [Related]
10. The concept of disease modification in spondyloarthropathy. Marzo-Ortega H; Emery P; McGonagle D J Rheumatol; 2002 Aug; 29(8):1583-5. PubMed ID: 12180712 [No Abstract] [Full Text] [Related]
11. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road. Bathon JM; Cohen SB Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712 [No Abstract] [Full Text] [Related]
12. Issues in rheumatology and autoimmunity. Preface. Sherer Y Isr Med Assoc J; 2008 Feb; 10(2):138. PubMed ID: 18432028 [No Abstract] [Full Text] [Related]
13. Assessment and management of rheumatoid arthritis. Haraoui B J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Umićević Mirkov M; Coenen MJ Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics in rheumatoid arthritis. Ranganathan P Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240 [TBL] [Abstract][Full Text] [Related]
16. Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs? Kremer J Arthritis Rheum; 2005 Oct; 53(5):636-8. PubMed ID: 16208649 [No Abstract] [Full Text] [Related]
20. Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database. Buchbinder R; March L; Lassere M; Briggs AM; Portek I; Reid C; Meehan A; Henderson L; Wengier L; van den Haak R Intern Med J; 2007 Sep; 37(9):591-600. PubMed ID: 17573817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]